Alex Kolicich

Investment Team
San Francisco, CA
[overview]

Alex Kolicich focuses on IT and Bio-IT investments.

Prior to joining 8VC, Alex was a Partner at Formation 8. Alex also worked with Peter Thiel as a Principal at Mithril Capital Management, a growth-stage venture fund, where he helped lead investments in AppDirect, C2FO and Helion Energy.

Preceding his venture career, Alex worked as engineer and early-product advisor at Clarium, Palantir, and Google. He was an early member of the Clarium Capital quantitative engineering team (with Joe Lonsdale) and close advisor/collaborator with the early Palantir team; advising on product design and contributing to the product. At Google Research, Alex worked on Google Street-Views before and during launch. Preceding Street-Views, also at Google, he worked on the development and launch of the Google Checkout product.

[Q&A]
Posts
News
Apr 14, 2022

Announcing Twingate’s Series B Funding Round

Earlier this week, Twingate announced their $42 million Series B, led by BOND. It has been an absolute pleasure working with the Twingate team since day one when we co-led their seed and Series A rounds. It has been wonderful watching the team bring the zero trust vision to network security and we wanted to share some of the thinking around why we believe the opportunity and Twingate’s approach are truly special.

Posts
News
Apr 14, 2022

Announcing Twingate’s Series B Funding Round

Earlier this week, Twingate announced their $42 million Series B, led by BOND. It has been an absolute pleasure working with the Twingate team since day one when we co-led their seed and Series A rounds. It has been wonderful watching the team bring the zero trust vision to network security and we wanted to share some of the thinking around why we believe the opportunity and Twingate’s approach are truly special.

Posts
News
Mar 15, 2022

Less Risk, More Practice

Earlier this month, Fieldguide announced their $17 million Series A, led by 8VC. Fieldguide CEO Jin Chang’s excellent blog post conveys both the tremendous functional appetite for their platform, and their larger mission to empower risk practices to increase trust in commerce and capital markets.

Posts
News
Mar 15, 2022

Less Risk, More Practice

Earlier this month, Fieldguide announced their $17 million Series A, led by 8VC. Fieldguide CEO Jin Chang’s excellent blog post conveys both the tremendous functional appetite for their platform, and their larger mission to empower risk practices to increase trust in commerce and capital markets.

Posts
News
Feb 18, 2022

Announcing Subskribe Series A

Over the past few years, we’ve watched as subscriptions have become both an increasingly prevalent business model for leading software businesses, as well as a modernizing force for legacy companies.

Posts
News
Feb 18, 2022

Announcing Subskribe Series A

Over the past few years, we’ve watched as subscriptions have become both an increasingly prevalent business model for leading software businesses, as well as a modernizing force for legacy companies.

Posts
News
Jan 15, 2022

Working at the Speed of Thought: Investing in Wispr AI

The essence of being a good venture capitalist is making moonshot bets. Sometimes that means backing entrepreneurs who build new software workflows for stagnant, legacy industries; other times, it means backing entrepreneurs who push the boundaries of what we can do as humans and as a society by building platforms to capitalize on breakthroughs in fundamental research.

Posts
News
Jan 15, 2022

Working at the Speed of Thought: Investing in Wispr AI

The essence of being a good venture capitalist is making moonshot bets. Sometimes that means backing entrepreneurs who build new software workflows for stagnant, legacy industries; other times, it means backing entrepreneurs who push the boundaries of what we can do as humans and as a society by building platforms to capitalize on breakthroughs in fundamental research.

Posts
News
Jun 18, 2020

Announcing Our Investment in Orca Bio

Every year in America, roughly 23,000 people undergo a Bone Marrow Transplant (BMT). These procedures are typically last-line interventions to save cancer patients. When successful, the therapy is often curative.

Posts
News
Jun 18, 2020

Announcing Our Investment in Orca Bio

Every year in America, roughly 23,000 people undergo a Bone Marrow Transplant (BMT). These procedures are typically last-line interventions to save cancer patients. When successful, the therapy is often curative.

[content]